Net Cash Provided by (Used in) Financing Activities in USD of Imunon, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Imunon, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Imunon, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $106K.
  • Imunon, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9.06M.
  • Imunon, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$3.64M, a 154% decline from 2022.
  • Imunon, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.72M, a 87.7% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Imunon, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $106K 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q1 2023 $2.47M 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q1 2021 $40.5M +$34.7M +598% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 $5.79M +$4.04M +230% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q1 2019 $1.75M +$518K +41.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q1 2018 $1.24M -$2.08M -62.7% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $3.32M +$4.31M 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q1 2016 -$988K -$110K -12.5% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2016
Q1 2015 -$878K -$14.7M -106% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q1 2014 $13.8M -$6.97M -33.5% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 $20.8M +$20.8M 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q1 2012 -$46.3K -$4.94M -101% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q1 2011 $4.9M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012

Imunon, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $9.06M +$12.7M 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 -$3.64M -$10.4M -154% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $6.72M -$48M -87.7% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $54.8M +$36.8M +205% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $18M +$10.1M +129% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $7.84M -$2.74M -25.9% 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2021
2018 $10.6M -$25.9M -71% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020
2017 $36.5M +$33.8M +1261% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $2.68M -$1.4M -34.4% 01 Jan 2016 31 Dec 2016 10-K 27 Mar 2018
2015 $4.08M -$14.7M -78.3% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 $18.8M -$10.6M -36.1% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 $29.4M +$13.9M +89.4% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016
2012 $15.5M -$37.3M -70.6% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015
2011 $52.8M +$50.5M +2124% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014
2010 $2.38M 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.